|
HNRNPR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.02150004805446E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.72740000029081E-07 |
| Normal-vs-Stage2 |
1.87299999999668E-05 |
| Normal-vs-Stage3 |
8.59380000495236E-09 |
| Normal-vs-Stage4 |
5.33220000376033E-08 |
| Stage1-vs-Stage2 |
4.686800E-01 |
| Stage1-vs-Stage3 |
1.892850E-01 |
| Stage1-vs-Stage4 |
1.761820E-01 |
| Stage2-vs-Stage3 |
8.382800E-01 |
| Stage2-vs-Stage4 |
6.515800E-01 |
| Stage3-vs-Stage4 |
7.310400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.69770003294923E-09 |
| Normal-vs-AfricanAmerican |
3.238100E-02 |
| Normal-vs-Asian |
4.46679999988042E-07 |
| Caucasian-vs-AfricanAmerican |
9.055600E-02 |
| Caucasian-vs-Asian |
7.285400E-01 |
| AfricanAmerican-vs-Asian |
8.133900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.38010003425393E-09 |
| Normal-vs-Female |
8.77219999972922E-08 |
| Male-vs-Female |
1.391640E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.97439999963345E-07 |
| Normal-vs-Age(41-60Yrs) |
8.65320004539427E-09 |
| Normal-vs-Age(61-80Yrs) |
4.05050000207297E-08 |
| Normal-vs-Age(81-100Yrs) |
3.257600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.161200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.854800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.603400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.213400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.935400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.132200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.504200E-02 |
| Classical-VS-Follicular |
1.797430E-03 |
| Classical-VS-Other |
1.411800E-01 |
| Classical-VS-Normal |
1.55349999997334E-06 |
| Tall-VS-Follicular |
6.139000E-01 |
| Tall-VS-Other |
5.901800E-01 |
| Tall-VS-Normal |
7.45779999977714E-07 |
| Follicular-VS-Other |
8.338800E-01 |
| Follicular-VS-Normal |
1.55199997298183E-09 |
| Other-VS-Normal |
1.143320E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.81800019483092E-10 |
| Normal-vs-N1 |
8.02870003813183E-09 |
| N0-vs-N1 |
5.480000E-01 |
|
|
